Your browser doesn't support javascript.
loading
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.
Khan, Khurum H; Cunningham, David; Werner, Benjamin; Vlachogiannis, Georgios; Spiteri, Inmaculada; Heide, Timon; Mateos, Javier Fernandez; Vatsiou, Alexandra; Lampis, Andrea; Damavandi, Mahnaz Darvish; Lote, Hazel; Huntingford, Ian Said; Hedayat, Somaieh; Chau, Ian; Tunariu, Nina; Mentrasti, Giulia; Trevisani, Francesco; Rao, Sheela; Anandappa, Gayathri; Watkins, David; Starling, Naureen; Thomas, Janet; Peckitt, Clare; Khan, Nasir; Rugge, Massimo; Begum, Ruwaida; Hezelova, Blanka; Bryant, Annette; Jones, Thomas; Proszek, Paula; Fassan, Matteo; Hahne, Jens C; Hubank, Michael; Braconi, Chiara; Sottoriva, Andrea; Valeri, Nicola.
Afiliação
  • Khan KH; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Cunningham D; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Werner B; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Vlachogiannis G; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
  • Spiteri I; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Heide T; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
  • Mateos JF; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
  • Vatsiou A; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Lampis A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
  • Damavandi MD; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
  • Lote H; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Huntingford IS; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Hedayat S; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Chau I; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Tunariu N; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Mentrasti G; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Trevisani F; Department of Radiology, The Royal Marsden NHS Trust, Londonand Sutton, United Kingdom.
  • Rao S; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Anandappa G; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Watkins D; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Starling N; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Thomas J; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Peckitt C; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Khan N; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Rugge M; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Begum R; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Hezelova B; Department of Radiology, The Royal Marsden NHS Trust, Londonand Sutton, United Kingdom.
  • Bryant A; Department of Medicine and Surgical Pathology, University of Padua, Padua, Italy.
  • Jones T; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Proszek P; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Fassan M; Department of Medicine, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Hahne JC; Clinical Genomics, The Centre for Molecular Pathology, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Hubank M; Clinical Genomics, The Centre for Molecular Pathology, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
  • Braconi C; Department of Medicine and Surgical Pathology, University of Padua, Padua, Italy.
  • Sottoriva A; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, United Kingdom.
  • Valeri N; Clinical Genomics, The Centre for Molecular Pathology, The Royal Marsden NHS Trust, London and Sutton, United Kingdom.
Cancer Discov ; 8(10): 1270-1285, 2018 10.
Article em En | MEDLINE | ID: mdl-30166348
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Biópsia Líquida Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Biópsia Líquida Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido